2021
DOI: 10.1002/art.41719
|View full text |Cite
|
Sign up to set email alerts
|

Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients Receiving Combination Therapy: Comment on the Article by Curtis et al

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…A biological TNF antagonist inhibiting the interaction of TNF-α and lymphotoxin (TNF-β) with cell-surface receptors, whereby TNF-mediated cellular responses and the activity of other pro-inflammatory cytokines are modulated. [181][182][183][184]…”
Section: Etanercept)mentioning
confidence: 99%
“…A biological TNF antagonist inhibiting the interaction of TNF-α and lymphotoxin (TNF-β) with cell-surface receptors, whereby TNF-mediated cellular responses and the activity of other pro-inflammatory cytokines are modulated. [181][182][183][184]…”
Section: Etanercept)mentioning
confidence: 99%